Stockscreener 앱 받기
15.63
1.08%
-0.17
시간 외 거래:
15.60
-0.03
-0.19%
전일 마감가:
$15.80
열려 있는:
$15.99
하루 거래량:
2.38M
Relative Volume:
0.88
시가총액:
$2.34B
수익:
$5.75B
순이익/손실:
$77.00M
주가수익비율:
31.90
EPS:
0.49
순현금흐름:
$-675.00M
1주 성능:
+2.42%
1개월 성능:
+29.28%
6개월 성능:
+10.30%
1년 성능:
-18.17%
1일 변동 폭
$15.41
$16.00
1주일 범위
$15.19
$16.52
52주 변동 폭
$9.13
$19.75
Chemours Company Stock (CC) Company Profile
명칭
Chemours Company
전화
302 773 1000
주소
1007 MARKET STREET, WILMINGTON, DE
CC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CC
Chemours Company
|
15.63 | 2.37B | 5.75B | 77.00M | -675.00M | 0.49 |
|
LIN
Linde plc Ordinary Share
|
453.03 | 212.48B | 33.50B | 7.25B | 5.08B | 14.94 |
|
SHW
Sherwin Williams Co
|
346.08 | 86.35B | 23.28B | 2.57B | 2.43B | 10.24 |
|
ECL
Ecolab Inc
|
284.09 | 80.35B | 15.89B | 2.00B | 1.55B | 6.9525 |
|
APD
Air Products Chemicals Inc
|
259.12 | 58.46B | 12.04B | -346.40M | -3.77B | -1.7734 |
|
PPG
Ppg Industries Inc
|
110.28 | 25.28B | 16.18B | 1.32B | 807.00M | 5.6399 |
Chemours Company Stock (CC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-27 | 업그레이드 | Mizuho | Neutral → Outperform |
| 2025-01-28 | 개시 | Truist | Buy |
| 2024-07-09 | 업그레이드 | UBS | Neutral → Buy |
| 2024-06-07 | 개시 | Mizuho | Neutral |
| 2024-04-09 | 업그레이드 | BMO Capital Markets | Underperform → Outperform |
| 2024-03-05 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-02-29 | 다운그레이드 | BMO Capital Markets | Outperform → Underperform |
| 2023-12-01 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-06-22 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-01-24 | 업그레이드 | UBS | Neutral → Buy |
| 2023-01-11 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-01-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-01 | 개시 | Credit Suisse | Underperform |
| 2022-10-13 | 개시 | Goldman | Neutral |
| 2022-10-05 | 다운그레이드 | Argus | Buy → Hold |
| 2022-06-14 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-06-10 | 개시 | Wolfe Research | Outperform |
| 2021-06-09 | 업그레이드 | Goldman | Neutral → Buy |
| 2021-05-20 | 개시 | BofA Securities | Buy |
| 2021-05-06 | 업그레이드 | Argus | Hold → Buy |
| 2021-01-08 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-12-04 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2020-11-30 | 개시 | Alembic Global Advisors | Overweight |
| 2020-03-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2020-02-14 | 업그레이드 | CFRA | Buy → Strong Buy |
| 2019-11-06 | 업그레이드 | CFRA | Hold → Buy |
| 2019-08-20 | 업그레이드 | Susquehanna | Neutral → Positive |
| 2019-08-09 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-08-06 | 다운그레이드 | Argus | Buy → Hold |
| 2019-08-05 | 다운그레이드 | SunTrust | Buy → Hold |
| 2019-07-12 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-05-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-04-15 | 업그레이드 | SunTrust | Hold → Buy |
| 2019-02-19 | 다운그레이드 | Susquehanna | Positive → Neutral |
| 2019-01-08 | 개시 | HSBC Securities | Buy |
| 2019-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-11-02 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-07-18 | 개시 | RBC Capital Mkts | Outperform |
| 2018-01-30 | 개시 | Morgan Stanley | Equal-Weight |
| 2017-12-06 | 다운그레이드 | Goldman | Buy → Neutral |
| 2017-08-07 | 업그레이드 | UBS | Sell → Neutral |
모두보기
Chemours Company 주식(CC)의 최신 뉴스
Chemours to sell titanium dioxide plant for $360M - delawarebusinesstimes.com
Spotlight on Leadership: A Conversation With Denise Dignam, President and CEO of Chemours - CSRwire
Chemours Stock Under Pressure: Is CC Turning into a Deep-Value Contrarian Bet? - AD HOC NEWS
SG Americas Securities LLC Has $647,000 Position in The Chemours Company $CC - MarketBeat
Chemours New Johnsonville Site Earns Silver Level in Tennessee Veteran Ready Program - CSRwire
Chemours (CC) Is Up 8.2% After Taiwan TiO₂ Sale Boosts Liquidity Flexibility Has The Bull Case Changed? - simplywall.st
Chemours Announces Process Innovation with New Viton™ Fluoroelastomers Advanced Polymer Architecture (APA) Offering - CSRwire
Trading the Move, Not the Narrative: (CC) Edition - Stock Traders Daily
Chemours (NYSE:CC) Given New $21.00 Price Target at Truist Financial - MarketBeat
CC: Truist Securities Raises Chemours Price Target to $21 | CC S - GuruFocus
A Glimpse Into The Expert Outlook On Chemours Through 5 Analysts - Benzinga
Did Chemours’ (CC) Taiwan Asset Sale and Debt Move Just Shift Its PFAS Risk Narrative? - Yahoo Finance
Chemours trying to close in on key technical measure - MSN
The Chemours Company to Sell Former Titanium Dioxide Site in Taiwan - Coatings World
Chemours price target raised to $20 from $18 at BMO Capital - Yahoo Finance
Chemours agrees to sell former titanium dioxide site in Taiwan - European Coatings
Chemours Trying To Close In On Key Technical Measure - Investor's Business Daily
Chemours signs deal to divest former TiO₂ site in Taiwan - ALCHEMPro
Chemours to sell former titanium dioxide site in Taiwan - European Rubber Journal
Assessing Chemours (CC) Valuation After PFAS Class Action Lawsuit Advances - simplywall.st
The Chemours Company: Is This Beaten-Down Chemicals Stock Quietly Resetting for a Turnaround? - AD HOC NEWS
Aug Big Picture: What is the PEG ratio of The Chemours CompanyWeekly Trade Report & Capital Protection Trading Alerts - baoquankhu1.vn
Chemours to sell Taiwan land for $360 million, plans debt reduction - Indian Chemical News
Chemours stock price target raised to $20 from $18 at BMO Capital By Investing.com - Investing.com South Africa
The Chemours Co (CC) Stock Price Up 4.11% on Jan 16 - GuruFocus
CC to Sell Former Titanium Dioxide Taiwan Site Land for $360M - Finviz
Chemours stock price target raised to $20 from $18 at BMO Capital - Investing.com India
RBC Capital Adjusts Price Target on Chemours to $18 From $16, Maintains Outperform Rating - marketscreener.com
Chemours to Sell Taiwan Site Land, Reduce Debt - TipRanks
The Chemours Company Moves Forward with Sale of Former Titanium Dioxide Facility in Taiwan - ChemAnalyst
Chemours to sell former Taiwan titanium dioxide site for $360 million - Investing.com Nigeria
The Chemours Company agrees to sell former titanium dioxide site in Taiwan - marketscreener.com
The Chemours Company Agrees To Sell Former Titanium Dioxide Site In Taiwan - TradingView
Chemours to sell former Taiwan titanium dioxide site for $360 million By Investing.com - Investing.com India
Chemours Sells Taiwan Titanium Site for $360 Million Cash - Intellectia AI
Chemours (CC) to Sell Land in Taiwan, Plans Debt Reduction - GuruFocus
The Chemours Company Agrees to Sell Former Titanium Dioxide Site in Taiwan - PR Newswire
Lobbying Update: $80,000 of THE CHEMOURS COMPANY lobbying was just disclosed - Quiver Quantitative
Insider Sell: Is The Chemours Company a defensive stockQuarterly Profit Summary & Low Drawdown Momentum Ideas - baoquankhu1.vn
Why Chemours (CC) Is Up 14.5% After PFAS RICO Claims Survive Key Court Challenge - simplywall.st
Hafnium Market Hits New High with Major Key Players Chemours Company . Global Tungsten & Powders Corp. - openPR.com
Glycolic Acid Market is expected to generate a revenue of USD 461.74 Million by 2032, Globally, at 5.73% CAGR: Verified Market Research® - GlobeNewswire Inc.
ChemSec issues low grades to US chemical manufacturers - Manufacturing Dive
A New Year Perspective: Trusted Chemistry - ACCESS Newswire
Aug Closing: Can The Chemours Company stock weather global recessionTrade Analysis Report & AI Based Buy/Sell Signal Reports - Bộ Nội Vụ
Trade Recap: Will The Chemours Company stock gain from strong economyEntry Point & Long Hold Capital Preservation Tips - Bộ Nội Vụ
Weekly Earnings: Will The Chemours Company 2CU stock benefit from sector leadershipWeekly Trading Summary & Safe Capital Growth Plans - moha.gov.vn
(CC) Volatility Zones as Tactical Triggers - Stock Traders Daily
Will The Chemours Company (2CU) stock benefit from sector leadership2025 Market WrapUp & Weekly Stock Breakout Alerts - Улправда
As EPA tries to loosen PFAS rules, NC regulators inch toward statewide protections - Raleigh News & Observer
Will The Chemours Company (2CU) stock announce a stock splitSector-Based Investing & Easy Tools to Analyze Your Investment Risk - bollywoodhelpline.com
Chemours Company (CC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
0.93%
자본화:
|
볼륨(24시간):